IJC Recap: MIGS and the Cornea, a New Take on Punctal Occlusion, and a Preservative-Free Latanoprost Formulation
In the Innovation Journal Club (IJC) series on Eyetube.net, host I. Paul Singh, MD, of The Eye Centers of Racine & Kenosha in Wisconsin, interviews leading experts from across eye care subspecialties about emerging innovations and technologies that may prove influential to the real-world practice of ophthalmology. The series is editorially independent (supported by advertising from multiple companies), which allows the discussions to be broad in scope and candid in presentation.
The following is a summary of three episodes in which Dr. Singh spoke with Arsham Sheybani, MD, about corneal endothelial health and MIGS procedures, Brandon Ayres, MD, about a novel crosslinked hyaluronate canalicular gel occlusive for dry eye disease (DED), and Jason Bacharach, MD, about the clinical impact of a preservative-free latanoprost formulation.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- IJC Recap: MIGS and the Cornea, a New Take on Punctal Occlusion, and a Preservative-Free Latanoprost Formulation
Comparing 5-Year Corneal Endothelial Safety of Multiple MIGS Devices
Arsham Sheybani, MDArsham Sheybani, MD - IJC Recap: MIGS and the Cornea, a New Take on Punctal Occlusion, and a Preservative-Free Latanoprost Formulation
Evaluating Novel Crosslinked Hyaluronate Canalicular Gel Occlusive for DED
Brandon D. Ayres, MDBrandon D. Ayres, MD - IJC Recap: MIGS and the Cornea, a New Take on Punctal Occlusion, and a Preservative-Free Latanoprost Formulation
Patient-Reported Outcomes After Switching to or Starting Preservative-Free Latanoprost
Jason Bacharach, MDJason Bacharach, MD
